These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 19185628

  • 1. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC.
    Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
    [Abstract] [Full Text] [Related]

  • 2. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM.
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [Abstract] [Full Text] [Related]

  • 3. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 4. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Hernandez AF.
    J Am Coll Cardiol; 2013 Sep 24; 62(13):1177-83. PubMed ID: 23747790
    [Abstract] [Full Text] [Related]

  • 5. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
    Howlett JG, Ezekowitz JA, Podder M, Hernandez AF, Diaz R, Dickstein K, Dunlap ME, Corbalán R, Armstrong PW, Starling RC, O'Connor CM, Califf RM, Fonarow GC, ASCEND-HF Investigators.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):534-42. PubMed ID: 23899930
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA, Ng TM, Van Tassell BW.
    Pharmacotherapy; 2007 May 01; 27(5):619-25. PubMed ID: 17461695
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT.
    Rev Cardiovasc Med; 2004 May 01; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [Abstract] [Full Text] [Related]

  • 9. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.
    Albert NM.
    J Am Acad Nurse Pract; 2005 Oct 01; 17(10):403-10. PubMed ID: 16181262
    [Abstract] [Full Text] [Related]

  • 10. Acute decompensated heart failure: best evidence and current practice.
    Mehta R, Feldman D.
    Minerva Cardioangiol; 2005 Dec 01; 53(6):537-47. PubMed ID: 16333237
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA, Hernandez AF.
    Expert Rev Cardiovasc Ther; 2010 Feb 01; 8(2):159-69. PubMed ID: 20136602
    [Abstract] [Full Text] [Related]

  • 12. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S, Chen HH.
    Expert Rev Cardiovasc Ther; 2012 May 01; 10(5):557-63. PubMed ID: 22651831
    [Abstract] [Full Text] [Related]

  • 13. Acute decompensated heart failure: challenges and opportunities.
    Fonarow GC.
    Rev Cardiovasc Med; 2007 May 01; 8 Suppl 5():S3-12. PubMed ID: 18192951
    [Abstract] [Full Text] [Related]

  • 14. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA.
    Pharmacotherapy; 2007 May 01; 27(5):626-32. PubMed ID: 17461696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
    Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, Bakal JA, Califf RM, McMurray JJ, Armstrong PW.
    J Am Coll Cardiol; 2012 Apr 17; 59(16):1441-8. PubMed ID: 22497823
    [Abstract] [Full Text] [Related]

  • 20. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.
    Circulation; 2014 Sep 16; 130(12):958-65. PubMed ID: 25074507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.